Loading clinical trials...
Loading clinical trials...
A Randomized, Open-label Study of the Effect of Oral Valcyte Versus Intravenous Ganciclovir on CMV Viremia in Solid Organ Transplant Patients
Conditions
Interventions
Ganciclovir
valganciclovir [Valcyte]
Locations
50
Australia
Chermside, Australia
Darlinghurst, Australia
Sydney, Australia
Woolloongabba, Australia
Vienna, Austria
Brussels, Belgium
Start Date
April 1, 2004
Primary Completion Date
August 1, 2008
Completion Date
August 1, 2008
Last Updated
November 2, 2016
NCT07294547
NCT06926894
NCT05626530
NCT02007356
NCT05089630
NCT04693637
Lead Sponsor
Hoffmann-La Roche
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions